Pediatria Polska

Abstract

3/2021 vol. 96
Case report

From the hypertransaminasemia symptoms to the recognition of late-onset Pompe disease in a 12-year-old boy

  1. Chair and Department of Paediatrics in Zabrze, Medical University of Silesia in Katowice, Poland
Pediatr Pol 2021; 96 (3): 220–222
Online publish date: 2021/09/29
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
The paper presents the case of a 12-year-old boy hospitalised due to persistent hypertransaminasemia of unknown origin, in whom rare metabolic disease – Pompe disease, was finally diagnosed. We discuss the possible symptoms and the diagnostic criteria for Pompe disease, as well as modern genetic methods of diagnosing. The importance of including this metabolic disease in differential diagnosis of hypertransaminasemia was underlined. The recombinant human α-glucosidase as the enzyme replacement therapy makes nowadays the early diagnosis of Pompe disease especially important.
Share
without publication fees
without publication fees